drugset / Trial / NCT00280280

Botox vs. Baclofen for Upper Limb Spasticity

NCT00280280

Phase 1 Terminated 8 enrolled Vanderbilt University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of this pilot study are to evaluate the safety and efficacy of Botox® compared to the safety and efficacy of oral baclofen in reducing muscle tone-related disability resulting from neurological damage or a stable neurological disorder and to evaluate drug-therapy tolerance.

Timeline

Start
2006-02
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 10 mg Oral
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Intramuscular

Indications

No indication recorded.